AusCann is an Australian-based company focused on the development and commercialisation of cannabinoid-derived therapeutic products to address unmet needs for humans and animals within Australia and internationally.
AusCann is an Australian-based company focused on the development and commercialisation of cannabinoid-derived therapeutic products to address unmet needs for humans and animals within Australia and internationally. Our key difference is the commitment to rigorous product development, focused on providing reliable, stable and standardised cannabinoid-derived therapeutics products, whilst generating robust safety, quality assurance and efficacy data to support market access in various regulatory environments around the world.
We have built a strong team of experts and partners in both human and animal health, with the right expertise across all aspects of both the pharmaceutical and nutraceutical value chains. Our immediate focus is on providing both healthcare professionals and veterinarians with solutions to optimise treatment outcomes for patients and for pets. To do that, we have developed innovative technologies to enhance the delivery of our novel formulations and aim to commercialise our products through various regulatory frameworks around the world.
Revolutionising cannabinoid-based medicines through innovation
To develop a differentiated portfolio of innovative and standardised cannabinoid-based medicines that expands the therapeutic applications of cannabis, offering both people and pets greater benefit for the treatment of inadequately met medical needs. We will do this by providing healthcare professionals and veterinarians with reliable pharmaceutical and nutraceutical products, with robust safety, quality assurance and efficacy data to support the treatment of their patients in global jurisdictions with relevant legislation that offer a compelling return on investment.
To act with integrity and the highest standards of ethics when dealing with stakeholders, including employees, suppliers, partners, customers and shareholders
To support healthcare professionals regarding the use of cannabinoid-based pharmaceuticals, through education with informed materials
To trust colleagues, share information and achieve organisational goals by working together as an effective team
To ensure that AusCann’s products are standardised, consistent and reproduceable, based on Good Manufacturing Practice
To develop and manufacture novel cannabinoid-based pharmaceuticals that are formulated to address unmet medical needs for patients
Environmental, social and governance
To minimise our environmental footprint; ensure all products are socially sourced; and maintain exemplary corporate governance practices